Treating severely ill Covid-19 patients with the arthritis drug tocilizumab has no clinical benefit, according to the results of a trial stopped early due to an increase in deaths among those receiving it, AFP reports:
The trial, published Thursday in the BMJ medical journal, appeared to contradict earlier studies in which tocilizumab seemed to show promise in reducing the length of hospital stays for some patients.
The drug, a common treatment for arthritis, blocks a specific part of the body’s immune system that can go into overdrive in serious and critical Covid-19 cases.
Joe Biden has marked the start of his presidency by signing a flurry of executive orders on a suite of issues, including Covid-19, the environment, immigration and ethics.
Some of the executive actions undo significant actions from Donald Trump’s administration, including halting the travel ban from Muslim-majority countries, and ending the declaration of a national emergency used to justify funding construction of a wall on the US-Mexico border.Continue reading...